
Indian billionaires buy foreign companies as growth slows at home
Indian companies are increasingly acquiring foreign firms due to a slowdown in domestic growth, weak private investment, and better diversification opportunities abroad. This trend, marked by significant deals like Sun Pharma's acquisition of Organon & Co., reflects a strategic shift from past global sprees.




